Testing effectiveness (Phase 2)WithdrawnNCT00620607
What this trial is testing
HuC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas
Who this might be right for
Stomach NeoplasmsMetastatic or Locally Advanced Gastric CancerMetastatic or Local Advanced GE Junction Cancer
ImmunoGen, Inc.